DSM PHARMA SOLUTIONS

Active Pharmaceutical Ingredients

HIGH-QUALITY PRODUCTS

Address unmet patient needs


Since their discovery, scientific evidence continues to reinforce the therapeutic benefits of vitamin and carotenoid ingredients. More recently, cannabinoid actives have demonstrated significant potential too. 

Our high-quality active pharmaceutical ingredients undergo the strictest quality assurance protocol and industry-leading GMP-compliant manufacturing practices aligned with ICH Q7. With an extensive and well-connected global network, we ensure consistent across multiple regions around the world. Connect with one of our formulation experts for help choosing the right product form for your next drug innovation.

Explore our active pharmaceutical ingredients

HIGH-QUALITY PRODUCTS

Vitamins

When you partner with DSM, you get the broadest portfolio of proven, safe and innovative vitamin actives on the market. We are the first and only company in the world that can provide access to the US and Japanese Drug Master Files (DMFs) and the Certification of Suitability (CEPs) for all 13 essential vitamins, and Chinese DMFs for selected ingredients, giving pharmaceutical customers a competitive edge by accelerating the registration and market entry process.

HIGH-QUALITY PRODUCTS

Carotenoids

Carotenoids are natural pigments with important health benefits. Some carotenoids function as antioxidants to protect cells, organs and other tissue from free radical damage, which may contribute to the development of disorders including cancer and heart and eye diseases.1 This makes carotenoids, like β-carotene, important targets for drug development.   

 1 Black, H. S., Boehm, F., Edge, R., & Truscott, T. G. (2020). The Benefits and Risks of Certain Dietary Carotenoids that Exhibit both Anti- and Pro-Oxidative Mechanisms-A Comprehensive Review. Antioxidants (Basel, Switzerland), 9(3), 264. https://doi.org/10.3390/antiox9030264

 

HIGH-QUALITY PRODUCTS

Cannabinoids

The cannabinoid-based drug market is growing rapidly. To facilitate early-stage drug development in this emerging field of research, DSM has created an innovation platform to explore the full therapeutic potential of cannabinoid molecules, like cannabidiol (CBD).

Latest Articles